Ketoprofen: Non-alcoholic fatty liver disease and steatohepatitis: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1348-1349, 2011-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclophosphamide/dexamethasone: Non-alcoholic steatohepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Valproic acid: Obesity and non-alcoholic fatty liver disease in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1284, 2010-01 ,pp. : 43-43

Adis International

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease: a massive problem

By Day Christopher P  

Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. : 176-178

Royal College Of Physicians

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. : 2193-2198

Bentham Science Publishers

Access to resources Recommend Favorite